Emtricitabine CAS 143491-57-0

Product Description:

Product Name: Emtricitabine CAS NO: 143491-57-0

Synonyms:

4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one;

EMtricitabine (EMtriva);

Chemical & Physical Properties:

Appearance: White Powder

Assay :≥99.0%

Density: 1.82 g/cm3

Boiling Point: 443.3℃ at 760 mmHg

Melting Point: 136-140℃

Flash Point: 221.9℃

Refractive Index: 1.731

Vapor Pressure: 0mmHg at 25℃

Safety Information:

HS Code: 2934999090

WGK Germany: 3

RTECS: UW7360500

Emtricitabine (FTC), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection in adults and children.

Emtricitabine is also marketed in a fixed-dose combination with tenofovir (Viread) under the brand name Truvada.

A fixed-dose triple combination of emtricitabine, tenofovir and efavirenz (Sustiva, marketed by Bristol-Myers Squibb) was approved by the U.S. Food and Drug Administration (FDA) on July 12, 2006 under the brand name Atripla.

Emtricitabine makes up one fourth of the Quad pill (brand name: Stribild).

It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.